Logo image of VENU

VENU HOLDING CORP (VENU) Stock Fundamental Analysis

NYSEARCA:VENU - NYSE Arca - US92333E1047 - Common Stock - Currency: USD

9.86  -0.14 (-1.39%)

Fundamental Rating

2

Overall VENU gets a fundamental rating of 2 out of 10. We evaluated VENU against 0 industry peers in the Unkown industry. Both the profitability and financial health of VENU have multiple concerns. VENU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VENU had negative earnings in the past year.
In the past year VENU had a positive cash flow from operations.
VENU Yearly Net Income VS EBIT VS OCF VS FCFVENU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA -7.42%
ROE -14.42%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VENU Yearly ROA, ROE, ROICVENU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -10 -20 -30 -40

1.3 Margins

VENU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VENU Yearly Profit, Operating, Gross MarginsVENU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 20 -20 40 -40 -60 -80

More info and screens

3

2. Health

2.1 Basic Checks

VENU does not have a ROIC to compare to the WACC, probably because it is not profitable.
VENU has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, VENU has about the same debt to assets ratio.
VENU Yearly Shares OutstandingVENU Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M
VENU Yearly Total Debt VS Total AssetsVENU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.87 indicates that VENU is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.10 indicates that VENU is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 2.87
ROIC/WACCN/A
WACC10.03%
VENU Yearly LT Debt VS Equity VS FCFVENU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 2.06 indicates that VENU has no problem at all paying its short term obligations.
A Quick Ratio of 2.05 indicates that VENU has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 2.05
VENU Yearly Current Assets VS Current LiabilitesVENU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for VENU have decreased strongly by -47.37% in the last year.
Looking at the last year, VENU shows a very strong growth in Revenue. The Revenue has grown by 45.52%.
EPS 1Y (TTM)-47.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
Revenue 1Y (TTM)45.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%56.13%

3.2 Future

The Earnings Per Share is expected to grow by 100.39% on average over the next years. This is a very strong growth
VENU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 179.93% yearly.
EPS Next Y-133.14%
EPS Next 2Y90.77%
EPS Next 3Y100.39%
EPS Next 5YN/A
Revenue Next Year33.31%
Revenue Next 2Y94.19%
Revenue Next 3Y179.93%
Revenue Next 5YN/A

3.3 Evolution

VENU Yearly Revenue VS EstimatesVENU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
VENU Yearly EPS VS EstimatesVENU Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

VENU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 21.48, VENU is valued on the expensive side.
VENU's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE N/A
Fwd PE 21.48
VENU Price Earnings VS Forward Price EarningsVENU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VENU Per share dataVENU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

VENU's earnings are expected to grow with 100.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.77%
EPS Next 3Y100.39%

More info and screens

0

5. Dividend

5.1 Amount

VENU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VENU HOLDING CORP

NYSEARCA:VENU (2/21/2025, 8:04:00 PM)

9.86

-0.14 (-1.39%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.23%
Inst Owner ChangeN/A
Ins Owners55.93%
Ins Owner Change0%
Market Cap369.36M
Analysts82.86
Price Target15.3 (55.17%)
Short Float %0.13%
Short Ratio0.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.48
P/S 29.32
P/FCF N/A
P/OCF 76.27
P/B 5.06
P/tB 5.08
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)0.46
Fwd EY4.66%
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)0.13
OCFY1.31%
SpS0.34
BVpS1.95
TBVpS1.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.42%
ROE -14.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.78%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1841.76%
Cap/Sales 347.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 2.05
Altman-Z 2.87
F-ScoreN/A
WACC10.03%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
EPS Next Y-133.14%
EPS Next 2Y90.77%
EPS Next 3Y100.39%
EPS Next 5YN/A
Revenue 1Y (TTM)45.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%56.13%
Revenue Next Year33.31%
Revenue Next 2Y94.19%
Revenue Next 3Y179.93%
Revenue Next 5YN/A
EBIT growth 1Y-133.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-308.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-595.8%
OCF growth 3YN/A
OCF growth 5YN/A